Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
{{output}}
Background: The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a... ...
